What Matters to Patients: Metabolic Health Beyond Weight Loss

Published: 06 July 2023

  • Views:

    Views Icon 21884

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Radcliffe Medical Education bring together a distinguished panel of globally renowned experts who provide guidance on navigating the ever-changing landscape of obesity and metabolic health management. 

 

Under the chairmanship of Prof Jason Halford (University of Leeds, UK), the panel including Dr Lee Kaplan (Obesity, Metabolism and Nutrition Institute, Massachusetts General Hospital, US), Dr Fatima Cody Stanford (Massachusetts General Hospital, US) and Prof Filip Knop (University of Copenhagen, DK) explore the pressing unmet needs in obesity management. The panel discuss how to leverage patient-reported outcomes to improve care, unveil emerging clinical and pre-clinical data and chart the course for future strategies in this critical field. Gain access to the forefront of metabolic health management, empowering you to make informed decisions and shape the future of patient care.

 

Susie Birney, representing the European Coalition for People Living with Obesity (ECPO) from Dublin, IE, provides invaluable insights from a patient advocacy standpoint, emphasising the importance of patient-reported outcomes. Her insights shed light on the lived experiences of individuals with obesity and the importance of incorporating patient-reported outcomes in the management of obesity and metabolic health.

 

Presented, and recorded, at ECO 2023 in Dublin, IE.

EASO 23 IME Symposium: What Matters to Patients: Metabolic Health Beyond Weight Loss’ program: Boehringer Ingelheim (BI) has provided funding for this program. BI has had no input into the agenda, presentations or collateral content. Radcliffe Medical retains full and sole editorial control. It is not intended for healthcare professionals based in the UK or Ireland.

Key Learning Objectives

  • Describe the global incidence of obesity and limitations of existing pharmacological approaches
  • Recall pre-clinical data for emerging dual GLP-1/GCGR agonists in obesity
  • Recall clinical and safety data from dual GLP-1/GCGR agonists in obesity
  • Discuss the potential clinical impact of novel obesity agents
  • Describe a standardised approach toward patient reported outcomes in obesity

Target Audience

  • Endocrinologists
  • Diabetologists
  • Cardiologists
  • Primary Care Physicians
  • Any other allied HCPs

More from this programme

Part 1

Obesity and Current Unmet Needs

Dr Fatima Cody Stanford opens this symposium by examining the current obesity burden, estimated worldwide prevalence and avoidable fatalities. Additionally, she explores the historical context of obesity treatments and highlights the potential of anti-obesity medications, along with lifestyle interventions, in managing this chronic disease.

1 session
Obesity and Current Unmet Needs Watch now

Part 2

Patient Reported Outcomes

During this session, Susie Birney provides a valuable patient's perspective on obesity. She highlights the significance of patient-reported outcome measures (PROMs) in understanding the experiences and needs of individuals living with obesity, drawing from her own personal journey.

1 session
Patient Reported Outcomes Watch now

Part 3

The Concept of Mono, Dual & Triple Agonists

Dr Lee Kaplan takes the stage to explore the concept of mono, dual, and triple agonists and their implications in the field of obesity medicine. He delves into the design and potential benefits of these therapeutic approaches for managing obesity.

1 session
The Concept of Mono, Dual & Triple Agonists Watch now

Part 4

Emerging Clinical Data in GCGR/GLP-1R Agonism

During this session, Prof Filip Knop provides an overview of emerging clinical data related to future therapies for obesity. He focuses on efficacy and safety information obtained from phase 1 and 2 trials, shedding light on the potential of these therapies.

1 session
Emerging Clinical Data in GCGR/GLP-1R Agonism Watch now

Part 5

How will Emerging Data and PROs Impact Obesity Management?

The panel concludes the symposium with an engaging discussion focusing on the influence of emerging clinical data and patient-reported outcomes (PROs) on obesity management, while also addressing questions from the audience. 

1 session
How will Emerging Data and PROs Impact Obesity Management? Watch now

Faculty Biographies

Susie Birney

Susie Birney

Advocate for Obesity; EPCO Secretary

Susie Birney lives with a food disorder called ARFID; she understands that there is not only one cause for obesity and not one treatment which will always work. Type 2 Diabetes and other co-morbidities have been health barriers for her since her 30’s. Since 2016, Susie has been a patient representative with the ASOI and an Irish representative with ECPO. This led to the start of creating a national patient led organisation ICPO from 2018. She shares her experiences to help to improve the lives of those who live with obesity.

View full profile

Comments

You must be to comment. If you are not registered, you can register here.